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Dairy cattle are susceptible to increased incidence and severity of disease during the 
periparturient period and health disorders occurring during this time are especially 
problematic because they greatly impact the productive efficiency of cows in the 
ensuing lactation (Ingvartsen, 2006, Pinedo et al., 2010). Indeed, about 75% of disease 
incidence within herds occurs within the first month of lactation including disorders of 
economic significance such as mastitis, metritis, ketosis and displaced abomasum 
(LeBlanc et al., 2006).  As such, there have been numerous studies to better 
understand the underlying causes of both metabolic and infectious diseases around the 
time of parturition in order to design more effective management practices to reduce 
cow health disorders during the periparturient periods (Burke et al., 2010, Roche et al., 
2013).   
 
The ability of cows to resist the establishment of diseases during  the periparturient 
period is related to the efficiency of their immune system. The immune system consists 
of a variety of biological components and processes that serve to protect cows from the 
consequences of disease.  The primary roles of the immune system are to prevent 
microbial invasion of the body, eliminate existing infections and other sources of cellular 
injury, and restore tissues to normal function. In animals, the immune system utilizes a 
multifaceted network of physical, cellular and soluble factors to facilitate defense against 
a diverse array of microbial challenges.  This integrated system of defense mechanisms 
is highly regulated to maintain a delicate balance between the activation of immunity 
needed to prevent the establishment of disease and resolution of activity once the threat 
of invasion has passed.  This paper will provide a brief overview of the immune system, 
describe how suboptimal immune responses can fail to prevent disease, and outline 
current strategies to optimize immune responses in food-animals during times of 
increased susceptibility to disease. 
 
OVERVIEW OF THE IMMUNE SYSTEM 
 
A properly functioning immune system should protect animals from a variety of 
pathogenic organisms including viruses, bacteria and parasites.  To accomplish this 
task, the immune system utilizes a complex and dynamic network of defense 
mechanisms that can be conveniently separate into two distinct categories: innate 
immunity and adaptive or acquired immunity (Table 1).  Within both innate and adaptive 
immunity, defense mechanisms can be classified further into physical barriers, cell-
mediated immunity, and soluble or humoral immunity. 
 
Table 1. Categories of the immune system 
Innate Immunity Adaptive Immunity 
Non-specific or generic response Antigen-specific response 
Immediate following exposure (minutes) Delayed following exposure (days) 
Physical & mechanical barriers No physical/mechanical barriers 
Cellular and soluble factors Cellular and soluble factors 
No immune memory Immunological memory 




The innate immune system is the dominant host defense mechanism in most 
organisms.  Innate immunity includes the nonspecific components of the immune 
system that can respond to infectious microbes in a generic manner.  Components of 
innate immunity constitute the first line of defense against invading pathogens since 
they are already present or are activated quickly at the site of exposure.  Depending on 
the efficiency of innate defenses, microbes may be eliminated within minutes to hours 
following invasion. This initial line of defense can be so rapid and efficient that there 
may be no noticeable changes in normal physiological functions of tissues as a 
consequence of the attempted microbial invasion.  Because of its nonspecific nature, 
however, innate immune mechanisms are not augmented by repeated exposure to the 
same insult. Components of the innate immune system include physical and mechanical 
barriers, phagocytes, and various soluble mediators (Table 2).  Physical and 
mechanical barriers are essential for preventing pathogens from entering the body.  
Some examples of surface barrier defenses that impede microbial invasion include the 
skin, tears, and mucus.  Once pathogens are able to breach this initial line of defense, 
however, the cellular and soluble components of the innate immune response must act 
promptly to prevent the successful establishment of disease (Aitken et al., 2011).  
 
Pattern recognition receptors play a critical role in innate immunity by sensing the 
presence of invading pathogens that successfully breach surface barrier defenses.  
Pattern recognition receptors can be expressed on cell surfaces, secreted, or expressed 
intracellularly and function to recognize a range of microbial factors associated with 
infectious pathogens.  Collectively, this diverse array of conserved motifs unique to 
specific groups of microbes are referred to as pathogen-associated molecular patterns 
(PAMPs) and include, for example,  lipopeptides of gram-positive bacteria and 
lipopolysaccharide of gram-negative bacteria (Jungi et al., 2011, Kumar et al., 2011). 
Some examples of pattern recognition receptors found in both immune and non-immune 
cells within animals that can differentiate a range of PAMPs are CD14, nucleotide-
binding oligomerization domains (NOD), and the family of toll-like receptors (TLR) 
including TLR2, TLR4, TLR5, and TLR9 (Kumar et al., 2011). After binding to their 
ligand, pattern recognition receptors can initiate intracellular signaling cascades that 
result in initiation of innate immune responses or can facilitate antimicrobial activity 
directly (Aitken et al., 2011).   
 
Table 2. Components of innate immunity 
Factor Main Functions 
Physical barriers Block & trap microbes (skin, tears, mucus)
Pattern Recognition Receptors Surveillance and activation of innate 
immune responses  
Complement Bacteriolytic & facilitates phagocytosis 
Cytokines Pro-inflammatory & immunoregulatory 
Oxylipids (prostaglandins, leukotrienes) 
 
Pro-inflammatory & pro-resolving  
Endothelial Cells Regulates leukocyte migration & 
activation 
Neutrophils Phagocytosis and production of ROS 
Macrophages Phagocytosis; production of cytokines and 
oxylipids 
Dendritic Cells Phagocytosis; links innate & adaptive 
immunity 
Natural Killer Cells  Targets and helps to eliminate infected 
host cells  
 
Several endogenous soluble defenses of innate immunity can confront invading 
microbes that successfully enter the animal.  Depending on the site of invasion, some of 
these soluble factors can be either pre-existing or induced through signaling cascades 
upon recognition of microbial PAMPs by pattern recognition receptors on host cells. 
Complement, for example, is a component of the innate defense system that consists of 
a collection of proteins present in serum and other body fluids.  The proteins that 
comprise the complement system are synthesized mainly by hepatocytes, but other 
cellular sources include monocytes and tissue macrophages. Activation of the 
complement system can result in direct bactericidal activities from the deposition of 
pore-forming complexes (complement factors C3 and C5a) onto the surface of bacteria 
(Riollet et al., 2000).  Other important biological functions of complement that contribute 
to early microbial killing include opsonizing bacteria and priming or activating host 
immune cells for phagocytosis and intracellular killing.   Complement also is a potent 
chemoattractant for neutrophils and monocytes during the early stages of infection 
(Rainard, 2003). 
 
Cytokines are an excellent example of soluble innate defenses that are induced 
following activation of pattern recognition receptors by PAMPs.  For example, TLR 
activation leads to the activation of the NFB signaling pathway where enhanced 
cytokine expression is a major response. The cytokine network consists of a diverse 
group of proteins produced by both immune and non-immune cells throughout the entire 
body and under diverse circumstances.  The physiological and immunomodulatory 
capacity of the cytokine network is complex.  Individual cytokines can interact with other 
cytokines synergistically, additively, or antagonistically on multiple cell targets.   Several 
different cytokines can affect biological processes in the same way, as there is 
considerable functional redundancy within the cytokine network. Most cytokines have 
very short half-lives, so their synthesis and function usually occurs in bursts of activity 
(Sordillo and Streicher, 2002).  Cytokines are able to influence cellular functions through 
high affinity receptors for each cytokine located on host cells. Therefore, the activity of 
any responder cell is a function of not only the quantity and type of cytokine in the tissue 
microenvironment, but also the relative expression of cytokine receptors. With respect 
to innate immunity, cytokines exert their diverse effects by initiating the inflammatory 
response and facilitating the migration of leukocytes from blood into infected tissues 
following bacterial recognition by local cell populations.  The pattern of cytokine 
expression by cells in the body will differ depending on the type of pathogen that elicits 
their response.   In general, however, gram-negative bacteria initiate a greater 
magnitude of pro-inflammatory cytokine responses (i.e., IL1, IL6, IL8, and TNF when 
compared to gram-positive bacteria that tend to express a weaker and slower cytokine 
response during the early stages of infection. 
 
Oxylipids are a class of lipid mediators that contribute to innate immunity by 
regulating the onset, magnitude, and duration of the inflammatory response.  Oxylipids 
are synthesized from polyunsaturated fatty acid substrates primarily found in the cellular 
membrane including the omega-6 linoleic and arachidonic acids or the omega-3 
eicosapentaenoic (EPA) and docosahexaenoic acids (DHA) (Schmitz and Ecker, 2008). 
These fatty acid substrates are oxidized non-enzymatically by reactive oxygen species 
(ROS) or through different enzymatic pathways including the cyclooxygenases (COX), 
lipoxygenases (LOX), and cytochrome P450 pathways to produce a variety of oxylipids 
including prostaglandins (PG), thromboxanes (TX), leukotrienes (LT), and lipoxins. 
Depending on the timing and magnitude of expression, certain oxylipids can either 
enhance or resolve the inflammatory response.  Oxylipids can enhance inflammatory 
processes by increasing vascular permeability, leukocyte infiltration, localized edema, 
and fever. In response to microbial stimuli, for example, COX2 enzyme activity 
increases resulting in the biosynthesis of oxylipids with known vasoactive and 
proinflammatory properties such as PGE2, PGF2, and TXA2. Non-steroidal anti-
inflammatory drugs can inhibit PG and TX biosynthesis by targeting COX activity and 
are used to treat a variety of inflammatory-based diseases in food-animals. However, 
previous assumptions that all COX metabolites are solely responsible for propagating 
the inflammatory response is not supported by the current literature (Serhan et al., 
2008).  Whereas increased COX2 expression during the onset of inflammation is 
typified by PGE2 production, the presence of COX-derived PGD2 and 15d-PGJ2 are 
associated with the resolution of inflammation (Prasad et al., 2008). More recent studies 
have led to the discovery of anti-inflammatory lipoxins (LX) that are produced from the 
metabolism of hydroperoxy fatty acid intermediates by the 5LOX pathway (Serhan et al., 
2008). Omega-3 fatty acids also can be oxidized by COXs and LOXs to produce 
oxylipids with more anti-inflammatory or resolving properties (Schmitz and Ecker, 2008). 
For example, EPA is metabolized by 5LOX and modified forms of COX2 to produce E-
series resolvins, whereas 15LOX converts DHA to the D-series resolvins, protectins, 
and the macrophage-specific maresin (Serhan and Chiang, 2008). During uncontrolled 
inflammation, a combination of exacerbated production of pro-inflammatory oxylipids 
and diminished production of anti-inflammatory oxylipids prevents full resolution and 
restoration of homeostasis of the affected tissues. Therefore, the balance between 
production of pro- and anti-inflammatory oxylipids is one factor that determines the 




Inflammation is a critical component of the innate defense system that involves 
complex biological responses of both cellular and soluble factors following local tissue 
injury or trauma.  The purpose of host inflammatory responses is to eliminate the source 
of tissue injury, restore immune homeostasis, and return tissues to normal function.  
The inflammatory cascade results not only in the escalation of local antimicrobial 
factors, but also in the increased movement of leukocytes and plasma components from 
the blood into infected tissues. The clinical signs of inflammatory include redness, heat, 
swelling, and pain(Mattmiller et al., 2013).  These clinical symptoms can be explained 
by distinct changes in vascular endothelial responses.  For example, redness, heat, and 
pain are caused by increased blood flow as a consequence of enlarged vascular 
diameter.  Increased vascular permeability, resulting from the separation of tightly joined 
endothelial cells that line the blood vessel, leads to the exit of fluids and proteins from 
the blood and accumulated into tissues.  These events account for the swelling or 
edema associated with inflammation. 
 
In addition to changes in blood flow, the vascular endothelium also serves as a 
“gate-keeper” that regulates the movement of leukocytes from the blood vessels and 
into the affected tissues.  Host cells express pattern molecule receptors that become 
activated by PAMPs and then release various inflammatory mediators such as 
cytokines and oxylipids that initiate the inflammatory cascade. These inflammatory 
mediators act directly on vascular endothelium to cause reductions in blood velocity with 
a concomitant increased expression of adhesion molecules on endothelial cells. 
Adhesion molecules on leukocytes attach to vascular adhesion molecules to facilitate 
the migration of leukocytes from the blood to the site of injury (Maddox et al., 1999, 
Hodgkinson et al., 2007). Neutrophils are the predominant cell type to undergo this 
extravasation process during the early stages of inflammation. Neutrophils first 
marginate and then adhere to the local endothelium near the site of infection. Cytokines, 
oxylipids, and other mediator molecules stimulate adherent neutrophils to move 
between endothelial cells and pass the basement membrane into the damaged tissue 
areas. The movement of neutrophils within the tissues is facilitated by chemotactic 
gradients created by inflammatory mediator molecules at the localized site of infection. 
Neutrophil migration can occur quickly and accumulate within affected tissues as soon 
as 30 to 60 minutes following injury (Summers et al., 2010).  
 
Both newly recruited and pre-existing leukocyte populations act cooperatively to 
eliminate microbial pathogens. Macrophages localized within tissues respond to 
bacterial invasion by the release of immune-regulatory cytokines and oxylipids. Both 
macrophages and the newly recruited neutrophils also function to phagocytize and kill 
invading microbes. The process of phagocytosis involves the internalization of bacteria 
within phagosomes that contain bactericidal reactive oxygen species (ROS) and 
hydrolytic enzymes. The ROS are formed by respiratory burst activity that involves the 
activation of NADPH oxidase and the subsequent production of superoxide radicals and 
hydrogen peroxide (Sordillo and Aitken, 2009). Myeloperoxides can further combine 
hydrogen peroxide with chloride to produce hypochlorite that is associated with bacterial 
activities. In addition to phagocytosis, neutrophils can kill bacteria through extracellular 
mechanisms. Activated neutrophils can form neutrophil extracellular traps (NETs) that 
consist of a web of fibers composed of chromatin and serine proteases that trap and kill 
bacteria. Studies suggest that NETs provide a highly concentrated foci of antibacterial 
substances that bind and kill bacteria independently of phagocytic uptake in the 
mammary gland (Lippolis et al., 2006, Grinberg et al., 2008). NETs also may serve as a 
physical barrier that prevents further spread of bacteria throughout the mammary gland.   
 
Adaptive Immunity  
 
The adaptive immune response is triggered when innate immune mechanisms fail to 
eliminate a pathogen. The adaptive immune response is characterized by the 
generation of antigen-specific lymphocytes and memory cells with the ability to 
recognize specific antigenic determinants of a pathogen.  When host cells and tissues 
are re-exposed to the same antigen, a heightened state of immune reactivity occurs as 
a consequence of immunological memory and clonal expansion of antigen-specific 
effector cells.  A memory immune response would be much faster, considerably 
stronger, longer lasting, and often more effective in clearing an invading pathogen when 
compared to a primary immune response.  In contrast to the innate immune response, 
adaptive immunity can take days to develop because of the clonal expansion of B and T 
lymphocytes specific to the invading pathogen. An amazing feature of the immune 
system is the ability of a host to recognize and respond to billions of unique antigens 
that they may encounter. It also is important that an inappropriate specific immune 
response does not occur against the host’s own antigens.  For this reason, the immune 
system is able to distinguish self from non-self and selectively react to only foreign 
antigens.  Genetically diverse, membrane bound proteins called major histocompatibility 
complex (MHC) molecules assist in this recognition.  A specific immune response will 
only occur if antigens are combined with an MHC molecule on the surface of certain 
cells, a process referred to as antigen presentation (Sordillo and Aitken, 2011). The 
unique features of the adaptive immune response form the basis of vaccine strategies 
(Table 1).   
  
Generation of effective specific immunity involves two types of cells, lymphocytes 
and antigen presenting cells.  Lymphocytes recognize bacterial antigens through 
membrane receptors specific to the invading pathogen.  These are the cells that 
mediate the defining attributes of adaptive immunity including specificity, diversity, 
memory, and self/non-self recognition. The T- and B-lymphocytes are two distinct 
subsets of lymphocytes which differ in function and protein products.  The T 
lymphocytes can be further subdivided into  T-lymphocytes, which include CD4+ (T 
helper) and CD8+ (T cytotoxic) lymphocytes, and  T lymphocytes (Table 3).  
Depending on tissue location, the percentages of these cells can vary significantly 
(Sordillo and Streicher, 2002).   
 
Table 3. Components of Adaptive Immunity 
Factor Main Functions 
Major Histocompatibility Complex Recognizes self from non-self 
Dendritic Cells and Macrophages Antigen presentation cells 
T Lymphocytes CD4+ Cells or T helper Cells (Th1, 
Th2, Th17, Treg); produce cytokines 
that regulate innate and adaptive 
immunity; immunoglobulin isotype 
switching 
CD8+ Cells or T cytotoxic (Tc); attacks 
and kills cells that express foreign 
antigens (virus-infected) 




Antigen presentation; differentiate into 
antibody-producing plasma cells 
Immunoglobulin (antibodies) IgM is the largest and first produced; 
role in agglutination and complement 
activation 
IgG concentration is high in sera and is 
important for opsonization 
IgA is found at mucosal surfaces and 
has anti-viral function 
IgE is associated with allergic reactions 
and parasitic infections 
IgD non-secreted regulatory molecule 
 
Effector functions of T lymphocytes include the production of cytokines that facilitate 
cell-mediated immunity by regulating the magnitude and duration of the immune 
response. The T helper lymphocytes (TH1, TH2, TH17, and Treg) produce cytokines in 
response to recognition of antigen-MHC complexes on antigen presenting cells (B 
lymphocytes and macrophages).  When activated, T helper cells produce a variety of 
immunoregulatory cytokines.  Through the ability to secrete certain cytokines, T helper 
cells play an important role in activating both T and B lymphocytes, macrophages, 
neutrophils, and various other cells that participate in the immune response.  
Differences in the particular pattern of cytokines produced by activated T helper cells 
results in different types of immune responses.  For example, the cytokines IFN- and  
IL2 are thought to enhance some nonspecific cellular activities such as phagocytosis 
and intracellular killing (Sordillo and Aitken, 2011).   
 
Antigen-specific B lymphocytes synthesize and secrete antibodies or 
immunoglobulin (Ig) that recognize and counteract specific microbial virulence factors. 
Immunoglobulins are produced by antigen-activated B-lymphocytes that subsequently 
proliferate and differentiate into antibody-secreting plasma cells. There are 4 classes of 
immunoglobulins that are known to influence host defense against infectious pathogens, 
namely IgM, IgG, IgA and IgM, which all differ in their physiochemical and biological 
properties. For example, several Ig isotypes (IgG1, IgG2, and IgM) can act as opsonins 
to enhance phagocytosis by neutrophils and macrophages.  In addition to its role in 
opsonization, IgM is efficient at complement fixation.  Whereas IgA does not aid in 
bacterial opsonization, it does function in bacterial agglutination that can impede the 
ability of certain pathogens to spread throughout certain tissues.   Another important 
role of IgA is its ability to neutralize some bacterial toxins.  Clearly, both the 
concentration and isotype composition of Ig found in tissues can have a profound 
influence on the establishment of new infections. 
 
PERIPARTURIENT IMMUNE DYSFUNCTION 
 
The periparturient period is characterized as a time of dramatic changes in the 
efficiency of the bovine immune system.  Numerous studies have documented changes 
in many aspects of both innate and adaptive immunity that can impact the susceptibility 
to new diseases in the transition cow (Aitken et al., 2011). A poorly functioning immune 
system can result in a number of adverse consequences.  Not only are cows more likely 
to become infected when exposed to pathogenic organisms, but the severity of disease 
is also escalated. Dysfunctional inflammatory reactions that occur at both the systemic 
and local level, for example, are especially problematic because of the direct impact on 
disease pathogenesis in transition cows including metritis and mastitis.   Derangements 
in inflammatory responses can consist of a hyporesponsive state characterized by 
delayed migration of functionally adequate neutrophils and other innate immune factors 
during the early stages of disease.  Conversely, the lack of an appropriate balance 
between the initiation and resolution of inflammation can result in an overly robust or 
chronic inflammatory response characterized by extensive damage to host tissues.  An 
excellent example of the consequence of a dysfunctional immune response is the 
severity and duration of mastitis in early lactation cows.  Studies showed that the ability 
of mammary glands to promptly respond to Escherichia coli endotoxin during early 
lactation when compared to cows in mid-lactation (Grommers et al., 1989).  The 
delayed migration of neutrophils and their reduced antimicrobial activity was suggested 
to be the cause of more severe coliform mastitis in the periparturient period when 
compared to later stages of lactation (Shuster et al., 1996) (Hill, 1981). 
 
The underlying causes of dysfunctional inflammation during the transition period 
have been the subject of considerable research, with evidence to support a role for both 
endocrine and metabolic factors (Sordillo and Mavangira, 2014).  For example, 
increases in several steroid hormones around the time of parturition are at least partially 
responsible for the altered function of neutrophils (Burton et al., 2005).  Glucocorticoids 
are known to have potent immunosuppressive functions and plasma concentrations 
increase around the time of calving.   A mechanism by which glucocorticoids can impair 
blood neutrophil function is by inducing a down-regulation of L-selectin and CD18 
adhesion molecules needed for effective activation and migration to sites of tissue injury 
(Burton et al., 1995).  Furthermore, changes in estradiol and progesterone 
concentrations just prior to calving were reported to have direct and indirect effects on 
the functional capabilities of immune cell populations (Roth et al., 1982).  Changes in 
these steroid hormones do not overlap with the entire transition period; it is clear, 
therefore, that other factors associated with the transition period also contribute to 
inflammatory dysfunction.   
 
The role of negative energy balance (NEB) and changes in nutrient metabolism 
during the transition period has been implicated in the derangement of appropriate 
inflammatory responses (Sordillo and Raphael, 2013). In a series of elegant studies, for 
example, pregnant dairy cows were mastectomized to assess the impact of milk 
production and NEB on various immune parameters while still maintaining the 
endocrine changes associated with late pregnancy and parturition (Kimura et al., 1999, 
Kimura et al., 2002, Nonnecke et al., 2003).   The mastectomized cows experienced 
only moderate increases in NEFA when compared with the cows with intact mammary 
glands during the periparturient period. Although immune function was compromised 
briefly around calving in mastectomized cows, lymphocyte and neutrophil functions 
were diminished longer in cows with mammary glands (Kimura et al., 1999, Nonnecke 
et al., 2003).  These authors also reported a negative impact of lactation on the 
composition of peripheral blood leukocyte populations (Kimura et al., 2002). The major 
conclusion from these studies was that the act of parturition, with the associated 
changes in steroid hormone profiles, is not the major immunosuppressive factor in 
periparturient cows.  Instead, the increased metabolic demands of early lactation was 
likely responsible for the adverse impact on immune cell populations.  Indeed, there 
exist numerous studies that indicate how individual metabolic components may affect 
immune cell populations during the periparturient period including NEFA, 
betahydroxybutarate, changes in glucose and micronutrient availability (Sordillo and 
Mavangira, 2014).  Changes in nutrient metabolism may form the common linkages 
between dysfunctional immune responses and the increased incidence of both 
metabolic and infectious diseases in periparturient dairy cattle. 
 
BENEFITS OF OPTIMIZING IMMUNITY 
 
Optimal host defenses against infectious pathogens occur when both innate and 
adaptive immune mechanisms are tightly regulated to effectively eliminate the injurious 
insults and return tissues to homeostasis.  Rapid resolution of infections will eliminate 
bystander tissue damage and prevent any noticeable changes to the overall health and 
well being of food animals.  Some pathogens, however, have intrinsic properties that 
make the efficient elimination by the immune system difficult, and attempts by local 
defenses to achieve control often results in significant tissue damage and production 
losses. Whereas antibiotic therapy remains the mainstay for the treatment of many 
infectious diseases, there is a need for alternative and adjunct therapeutic options that 
target host immune responses.  The challenge is to selectively down-modulate harmful 
host responses without diminishing beneficial responses that facilitate elimination of 
invading pathogens.  In contrast to antimicrobial drugs used to treat diseases in food 
animals, strategies that target host responses will minimize the risk of drug residues and 
the possibility of developing drug resistant bacteria.   
 
 
The development of effective immunomodulatory strategies to control the 
establishment of disease can begin by understanding those conditions that compromise 
host defenses.  Considerable research has established that the physiological stress 
during the periparturient period in dairy cattle is closely associated with dysfunction of 
several components of the innate and adaptive immune response (Sordillo et al., 1997).  
Certain hormones associated with parturition can explain some of the adverse effects 
on immunity during the periparturient period.  Oxidative stress, however, can also 
compromise immune cells populations especially during times of enhanced metabolism 
or during inflammation (Sordillo and Aitken, 2009).  Activation of the immune response 
requires energy and the immune system must compete for essential nutrients that are 
otherwise being used for growth, muscle accretion, and milk production. The 
development of uncontrolled acute or chronic inflammatory responses to infectious 
pathogens can not only cause bystander damage to host tissues, but also repartition 
nutrients resulting in dramatic reductions in animal growth and productivity (Aitken et al., 
2011). Therefore, adjusting the nutrition of animals and improving management to 
reduce exposure to infectious pathogens can have a major impact on optimizing 
immunity in animals. 
 
The development of innovative strategies that can enhance an otherwise impaired 
immune response could have a major impact on the incidence of diseases in food-
producing animals.  The challenge that confronts researchers now is to gain a better 
understanding of the complex interactions between the pathogenesis of bacteria, host 
responses needed to eliminate the pathogens from host tissues, and methods to 
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